Stradefy Biosciences
PrivateLast Round
VC Round
Dec 1, 2021
Company Overview
Stradefy Biosciences is a biotechnology company that develops next-generation bioadhesive drug carriers for targeted oncology and immunology applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stradefy Biosciences Comparables
Compare Stradefy Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BreezeBio | 83% | |
| Xanadu Bio | 82% | |
| Nouveau BioSciences | 82% | |
Stradefy Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2021 |
Stradefy Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elm Street Ventures | VC Round |
| Yale University | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2021
Led by Elm Street Ventures with participation from Yale University.
Stradefy Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stradefy Biosciences's valuation, stock price, and market status.